GPEN 2006 Conference

Browse by

In honor of its 10-year anniversary, The GPEN Executive Committee and the Department of Pharmaceutical Chemistry at the University of Kansas are pleased to have hosted the 6th biennial GPEN conference, GPEN 2006, at the University of Kansas (Lawrence, KS) on October 25-27, 2006. This meeting included 37 podia and 85 posters presented by graduate students and postdoctoral fellows. In addition, leading experts from academia and industry instructed students in eight half-day short courses covering topics in the pharmaceutical sciences.

Visit the GPEN 2006 conference site.

Sub-communities within this community

Recent Submissions

Strategies in Personalized Medicine: The Role of Pharmaceutics in Predictive Drug Therapy

Giacomini, Kathleen M. (2006-09-25)
Extraction and Metabolism of NNK in the Isolated Perfused Lung System

Maertens, Laura A.; Hecht, Stephen S.; Zimmerman, Cheryl L. (2006-10-27)
Prednisolone acetate-eluting novel biodegradable vascular stents for implantation

Sarisozen, Can (2006-10-25)
Simple screening methods for prediction of intestinal lymphatic transport of lipophilic drugs

Gershkovich, Pavel; Hoffman, Amnon (2006-10-25)
Physical stability and mixed domain binding properties of the EC5 domain of e-cadherin

Zheng, Kai; Laurence, Jennifer S.; Middaugh, C. Russell; Siahaan, Teruna J. (2006-10-25)
Formulation and in vitro evaluation of organogels containing imiquimod for topical application

Samdancioglu, Sibel; Hekimoglu, Süeda; Hincal, A. Atilla (2006-10-25)
Experimental pitfalls in protein binding measurements

Schmidt, Stephan; Derendorf, Hartmut; Sahre, Martina; Burkhardt, Olaf (2006-10-27)
Discovery and evaluation of novel mura inhibitors

Han, Huijong; Schönbrunn, Ernst (2006-10-27)
The study of skin permeation mechanism and terpene-skin lipid interaction via nuclear magnetic resonance

Lim, Perry Fung Chye; Liu, Xiang Yang; Huang, Meng; Ho, Paul Chi Lui; Chan, Sui Yung (2006-10-27)
Interaction of lopinavir with MDR1, MRP1 and MRP2 efflux proteins

Agarwal, Sheetal; Pal, Dhananjay; Mitra, Ashim K. (2006-10-27)
In vitro intestinal transport of a poorly aqueous soluble drug and p-glycoprotein efflux using biorelevant medium simulating the intestinal fluids

Lind, Marriane L.; Jacobsen, Jette; Holm, René; Müllertz, Annette (2006-10-27)
Influence of lipid content of a liposome formulation used for solubilization of a poorly water-soluble drug on absorption through Caco-2 monolayers

Schneider, M.; Imanidis, G. (2006-10-27)
Automated permeability assessment of drugs formulated as solid dosage forms by means of sequential injection technique (SIA)

Motz, Stephan A.; Klimundová, Jana; Schaefer, Ulrich F.; Balbach, Stefan; Eichinger, Thomas; Solich, Petr; Lehr, Claus-Michael (2006-10-27)
Lymphatic absorption of subcutaneously administered proteins in sheep: Influence of different injection sites

Kota, J.; Porter, C. J. H.; Edwards, G. A.; McLennan, D. N.; Machavaram, K.; Charman, S. A. (2006-10-27)
Physicochemical investigations of a drug delivery oscillator

Bhalla, A. S.; Siegel, R. A. (2006-10-27)
Delivery of neuroactive peptide drugs to the brain via intranasal delivery

Cros, Cecile D.; Toth, Istvan; Blanchfield, Joanne T. (2006-10-27)
Freezing-induced perturbation of tertiary structure of monoclonal antibody

Liu, Lu; Jones, Latoya S.; Carpenter, John F. (2006-10-25)
Microcrystalline particles prepared by precipitation in the presence of stabilizing excipients

Zimmermann, A.; Elema, M. Ringkjøbing; Hansen, Thomas v. O.; Müllertz, Annette; Hovgaard, L. (2006-10-25)
Solid-state NMR studies of the effects of pharmaceutical processing on relaxation dynamics and implications to solidstate drug stability

Lubach, J. W.; Sperger, Diana; Schieber, Loren J.; Munson, Eric J. (2006-10-25)
In-situ measurement of solid phase transformations during dissolution testing

Aaltonen, Jaakko; Strachan, Clare J.; Peltonen, Leena; Hirvonen, Jouni; Rantanen, Jukka (2006-10-25)

Contact KU ScholarWorks
Lawrence, KS | Maps

The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.

Contact KU
Lawrence, KS | Maps